GeneCentric CEO: It is 'starting to become more challenging to fund a biotech company'

RESEARCH TRIANGLE PARK - Earlier this year, GeneCentric Therapeutics closed $7.5 million in an equity fundraising round, after closing $1.2 million in debt at

Related Keywords

Neil Hayes ,Chuck Perou ,Michael Milburn ,Myla Lai Goldman ,Genecentric Milburn ,Lineberger Cancer Center ,Genecentric Therapeutics ,Cancer Center ,